← Holders
Sarissa Capital Management LP
What Sarissa Capital Management LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1577524 · Filed Nov 16, 2026
- Positions
- 10
- Reported value
- $153.2M
- Opened
- 0
- Closed
- 0
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$180.4M8 positions
- Dec 31, 2025$222.9M9 positions
- Mar 31, 2026$157.6M9 positions
- Jun 30, 2026$177.9M10 positions
- Sep 30, 2026$153.2M10 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
INVAInnoviva, Inc. | 1.9M | ±0% | $40.1M | 26.2% |
IRWDIronwood Pharmaceuticals Inc | 9.2M | ±0% | $36.5M | 23.8% |
AMRNAmarin Corp Plcuk | 1.3M | −23.1% | $16.7M | 10.9% |
LNTHLantheus Holdings, Inc. | 166.9K | ±0% | $16.6M | 10.8% |
NBIXNeurocrine Biosciences Inc | 116.5K | ±0% | $16.5M | 10.8% |
CYTKCytokinetics Inc | 228.6K | ±0% | $15.1M | 9.8% |
BHVNBiohaven Ltd. | 582.3K | ±0% | $7.8M | 5.1% |
REGNRegeneron Pharmaceuticals, Inc. | 4.2K | ±0% | $3.2M | 2.1% |
VORVor Biopharma Inc. | 25.4K | ±0% | $484.6K | 0.3% |
BIIBBiogen Inc. | 950 | ±0% | $214.6K | 0.1% |